381 related articles for article (PubMed ID: 20591215)
21. A randomized controlled trial of postoperative tumor lysate-pulsed dendritic cells and cytokine-induced killer cells immunotherapy in patients with localized and locally advanced renal cell carcinoma.
Zhan HL; Gao X; Pu XY; Li W; Li ZJ; Zhou XF; Qiu JG
Chin Med J (Engl); 2012 Nov; 125(21):3771-7. PubMed ID: 23106871
[TBL] [Abstract][Full Text] [Related]
22. [Thymoglobulin efficiently expands cytokine-induced killer cells in a clinical-grade culture protocol].
Chen W; Lin D; Jiang Z; Yang Z; Song S; Zhou J; Zhou L; Sun Y; Yu H; Ma D
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jul; 30(7):681-5, 690. PubMed ID: 25001928
[TBL] [Abstract][Full Text] [Related]
23. 2003-2013, a valuable study: Autologous tumor lysate-pulsed dendritic cell immunotherapy with cytokine-induced killer cells improves survival in stage IV breast cancer.
Lin M; Liang S; Jiang F; Xu J; Zhu W; Qian W; Hu Y; Zhou Z; Chen J; Niu L; Xu K; Lv Y
Immunol Lett; 2017 Mar; 183():37-43. PubMed ID: 28143792
[TBL] [Abstract][Full Text] [Related]
24. [In vitro cytotox icity effects of cocultured DC-C IK cells combined with sorafenib against hepa to cellular carcinoma].
Zhang D; He JT
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jun; 27(6):664-7. PubMed ID: 21651871
[TBL] [Abstract][Full Text] [Related]
25. Optimizing tumor-associated antigen-stimulated autologous dendritic cell and cytokine-induced killer cell coculture to enhance cytotoxicity for cancer immunotherapy in manufacturing.
Lee YY; Luo SC; Lee CH; Tang CL; Shen CC; Cheng WY; Yang YC; Yang MY; Yen CM
BMC Immunol; 2023 Jun; 24(1):14. PubMed ID: 37386444
[TBL] [Abstract][Full Text] [Related]
26. [Coculture of dendritic cell with cytokine-induced killer results in a significant increase in cytotoxic activity of CIK to tumor cells in vitro and in vivo].
Ge W; Li CH; Zhang W; Han Q; Deng WM; Chen L; You SG; Zhao CH
Zhonghua Xue Ye Xue Za Zhi; 2004 May; 25(5):277-80. PubMed ID: 15182535
[TBL] [Abstract][Full Text] [Related]
27. Coculturing dendritic cells with zoledronate acid efficiently enhance the anti-tumor effects of cytokine-induced killer cells.
Su X; Zhang L; Jin L; Ye J; Guan Z; Chen R
J Clin Immunol; 2010 Sep; 30(5):766-74. PubMed ID: 20549316
[TBL] [Abstract][Full Text] [Related]
28. Cytokine-induced killer cells/dendritic cells-cytokine induced killer cells immunotherapy combined with chemotherapy for treatment of colorectal cancer in China: a meta-analysis of 29 trials involving 2,610 patients.
Zhang L; Mu Y; Zhang A; Xie J; Chen S; Xu F; Wang W; Zhang Y; Ren S; Zhou C
Oncotarget; 2017 Jul; 8(28):45164-45177. PubMed ID: 28404886
[TBL] [Abstract][Full Text] [Related]
29. [The proliferation profile in vitro and anti-tumor effects of dendritic cells co-culturing with CIK cells].
Zhang S; Wang EZ; Bai CX; Xu YH
Shi Yan Sheng Wu Xue Bao; 2003 Oct; 36(5):375-80. PubMed ID: 14724950
[TBL] [Abstract][Full Text] [Related]
30. [Efficacy of autologous renal tumor cell lysate-loaded dendritic cell vaccine in combination with cytokine-induced killer cells on advanced renal cell carcinoma--a report of ten cases].
Wang H; Zhou FJ; Wang QJ; Qin ZK; Huang LX; Liu ZW; Han H; Li YQ; Chen SP; Xia JC
Ai Zheng; 2006 May; 25(5):625-30. PubMed ID: 16687087
[TBL] [Abstract][Full Text] [Related]
31. Patient-derived dendritic cells transduced with an a-fetoprotein-encoding adenovirus and co-cultured with autologous cytokine-induced lymphocytes induce a specific and strong immune response against hepatocellular carcinoma cells.
González-Carmona MA; Märten A; Hoffmann P; Schneider C; Sievers E; Schmidt-Wolf IG; Sauerbruch T; Caselmann WH
Liver Int; 2006 Apr; 26(3):369-79. PubMed ID: 16584401
[TBL] [Abstract][Full Text] [Related]
32. Dendritic Cells Therapy with Cytokine-Induced Killer Cells and Activated Cytotoxic T Cells Attenuated Th2 Bias Immune Response.
Li C; Zhu D; Zhao Y; Guo Q; Sun W; Li L; Gao D; Zhao P
Immunol Invest; 2020 Jul; 49(5):522-534. PubMed ID: 31793363
[TBL] [Abstract][Full Text] [Related]
33. Effect of DC-CIK cell on the proliferation, apoptosis and differentiation of leukemia cells.
Qu HQ; Zhou XS; Zhou XL; Wang J
Asian Pac J Trop Med; 2014 Aug; 7(8):659-662. PubMed ID: 25149382
[TBL] [Abstract][Full Text] [Related]
34. Cytokine induced killer cell-based immunotherapies in patients with different stages of renal cell carcinoma.
Zhao X; Zhang Z; Li H; Huang J; Yang S; Xie T; Huang L; Yue D; Xu L; Wang L; Zhang W; Zhang Y
Cancer Lett; 2015 Jul; 362(2):192-8. PubMed ID: 25843292
[TBL] [Abstract][Full Text] [Related]
35. Clinical effect and safety of dendritic cell-cytokine-induced killer cell immunotherapy for pancreatic cancer: a systematic review and meta-analysis.
Liu YL; Yang LX; Zhang F; Tang BS; Zhao LT; Zhu JR; Jin QY; Wang RX; Li YM
Cytotherapy; 2019 Oct; 21(10):1064-1080. PubMed ID: 31462394
[TBL] [Abstract][Full Text] [Related]
36. Interactions between dendritic cells and cytokine-induced killer cells lead to an activation of both populations.
Märten A; Ziske C; Schöttker B; Renoth S; Weineck S; Buttgereit P; Schakowski F; von Rücker A; Sauerbruch T; Schmidt-Wolf IG
J Immunother; 2001; 24(6):502-10. PubMed ID: 11759073
[TBL] [Abstract][Full Text] [Related]
37. CIK cells from recurrent or refractory AML patients can be efficiently expanded in vitro and used for reduction of leukemic blasts in vivo.
Wang Y; Bo J; Dai HR; Lu XC; Lv HY; Yang B; Wang T; Han WD
Exp Hematol; 2013 Mar; 41(3):241-52.e3. PubMed ID: 23123634
[TBL] [Abstract][Full Text] [Related]
38. Dendritic cells decreased the concomitant expanded Tregs and Tregs related IL-35 in cytokine-induced killer cells and increased their cytotoxicity against leukemia cells.
Pan Y; Tao Q; Wang H; Xiong S; Zhang R; Chen T; Tao L; Zhai Z
PLoS One; 2014; 9(4):e93591. PubMed ID: 24705499
[TBL] [Abstract][Full Text] [Related]
39. [Tumor antigen-loaded dendritic cells combined with cytokine-induced killer (CIK) enhance the killing activity of human esophageal cancer cells by promoting ASK1 activation].
Duan Z; Li H; Hu B; Li Y; Huang L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Jun; 39(6):501-508. PubMed ID: 37340918
[TBL] [Abstract][Full Text] [Related]
40. Combination of DC/CIK adoptive T cell immunotherapy with chemotherapy in advanced non-small-cell lung cancer (NSCLC) patients: a prospective patients' preference-based study (PPPS).
Zhao Y; Qiao G; Wang X; Song Y; Zhou X; Jiang N; Zhou L; Huang H; Zhao J; Morse MA; Hobeika A; Ren J; Lyerly HK
Clin Transl Oncol; 2019 Jun; 21(6):721-728. PubMed ID: 30374838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
